CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

AMRUTANJAN HEALTH CARE LTD.

NSE : AMRUTANJANBSE : 590006ISIN CODE : INE098F01031Industry : Pharmaceuticals & DrugsHouse : Amrutanjan
BSE689.6541.35 (+6.38 %)
PREV CLOSE () 648.30
OPEN PRICE () 655.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2535
TODAY'S LOW / HIGH ()646.95 689.90
52 WK LOW / HIGH ()548.05 829
NSE687.4538 (+5.85 %)
PREV CLOSE() 649.45
OPEN PRICE () 654.50
BID PRICE (QTY) 687.45 (19)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 46159
TODAY'S LOW / HIGH() 642.10 692.35
52 WK LOW / HIGH ()544.1 842.9
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1936

Management Info :

S Sambhu Prasad - Chairman S Sambhu Prasad - Managing Director

Registered Office :

Address : New 103 (Old 42-45),Luz Church Road,Mylapore,
Chennai,
Tamil Nadu-600004

Phone : 044-24994164 / 24994146 / 24994465 / 24994366 / 24669000

Website : www.amrutanjan.com

Registrar's Details : Cameo Corporate Services Ltd
Subramanian Buildings No 1 ,Club House Road,,Chennai
Listing : BSE, NSE
NEWS
04Nov Amrutanjan Health Care informs about b
Pursuant to Regulation 29(1) of SEBI (Listing Obligations & Disclosu..
18Oct Amrutanjan Health Care informs about u
Pursuant to the Regulation 30 read with Clause 20 of Para A of Part A of..
07Jul Amrutanjan Health Care informs about R
Amrutanjan Health Care has informed that it enclosed the certificate iss..
07Apr Amrutanjan Health Care informs about c
Pursuant to Regulation 74 (5) of the SEBI (Depository Participants) Regu..
17Jul Amrutanjan Health Care informs about l
Amrutanjan Health Care has informed that the Company has received a requ..
Financials
in Millions
QTR Sep 25 ANNUAL 25
Net Profit139.6508.36
Gross Profit 192.13 691.35
Operating Profit 208.21758.8
Net Sales 11774518.16
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Bharat Parenterals (BSE)
 1128.80 (6.39%)
M.Cap ( in Cr)
777.96
Lupin (BSE)
 2114.10 (1.62%)
M.Cap ( in Cr)
96571.84
Panacea Biotec (BSE)
 362.70 (9.53%)
M.Cap ( in Cr)
2221.56
Emcure Pharma (BSE)
 1439.60 (2.18%)
M.Cap ( in Cr)
27289.76
Aurobindo Pharma (BSE)
 1193.70 (1.81%)
M.Cap ( in Cr)
69330.29
Shareholding Pattern
PROMOTERS 46.52%
NON-INSTITUTION 38.2%
MUTUAL FUNDS/UTI 7.55%
FI/BANKS/INSURANCE 0.09%
GOVERNMENT 0%
FII 0%
Mf Holding

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX85267.66449.53 (0.53%)
NIFTY26046.95148.40 (0.57%)
Dow Jones 48458.05-245.96 (-0.51%)
Nasdaq 23195.17-398.69 (-1.69%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI